EMC Instytut Medyczny SA owns hospitals and outpatient clinics in the private medical services market in Poland. More Details
Excellent balance sheet and fair value.
Share Price & News
How has EMC Instytut Medyczny's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EMC is more volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: EMC's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Polish stocks.
7 Day Return
1 Year Return
Return vs Industry: EMC exceeded the Polish Healthcare industry which returned 50.1% over the past year.
Return vs Market: EMC exceeded the Polish Market which returned -6.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is EMC Instytut Medyczny's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StInvestors Who Bought EMC Instytut Medyczny (WSE:EMC) Shares A Year Ago Are Now Up 185%
4 months ago | Simply Wall StIs There More Growth In Store For EMC Instytut Medyczny's (WSE:EMC) Returns On Capital?
5 months ago | Simply Wall StHere's Why EMC Instytut Medyczny (WSE:EMC) Has A Meaningful Debt Burden
Is EMC Instytut Medyczny undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: EMC (PLN13.7) is trading below our estimate of fair value (PLN689.58)
Significantly Below Fair Value: EMC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: EMC is unprofitable, so we can't compare its PE Ratio to the PL Healthcare industry average.
PE vs Market: EMC is unprofitable, so we can't compare its PE Ratio to the Polish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EMC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EMC is good value based on its PB Ratio (1.7x) compared to the PL Healthcare industry average (3.3x).
How is EMC Instytut Medyczny forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EMC Instytut Medyczny has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether EMC Instytut Medyczny is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- EMC Instytut Medyczny competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has EMC Instytut Medyczny performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EMC is currently unprofitable.
Growing Profit Margin: EMC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EMC is unprofitable, and losses have increased over the past 5 years at a rate of 1% per year.
Accelerating Growth: Unable to compare EMC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EMC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-0.3%).
Return on Equity
High ROE: EMC has a negative Return on Equity (-4.41%), as it is currently unprofitable.
How is EMC Instytut Medyczny's financial position?
Financial Position Analysis
Short Term Liabilities: EMC's short term assets (PLN111.2M) exceed its short term liabilities (PLN108.0M).
Long Term Liabilities: EMC's short term assets (PLN111.2M) exceed its long term liabilities (PLN90.5M).
Debt to Equity History and Analysis
Debt Level: EMC's debt to equity ratio (32.4%) is considered satisfactory.
Reducing Debt: EMC's debt to equity ratio has increased from 25% to 32.4% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable EMC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: EMC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 51.7% per year.
What is EMC Instytut Medyczny current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EMC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EMC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EMC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EMC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EMC's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Karol Piasecki (48 yo)
Mr. Karol Piasecki serves as President of the Management Board at EMC Instytut Medyczny SA since June 17, 2019.
|President of the Management Board||1.42yrs||zł334.00k||no data|
|Vice President of the Management Board & Investment Director||1.17yrs||zł128.00k||no data|
|Vice President of the Management Board & Financial Director||1.17yrs||zł272.00k||no data|
|Vice President of the Management Board & Operational Director||0.75yr||no data||no data|
|Chief Accountant||no data||no data||no data|
Experienced Management: EMC's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
|Chairman of the Supervisory Board||5.92yrs||zł11.00k||no data|
|Member of the Supervisory Board||2.83yrs||zł5.00k||no data|
|Member of the Supervisory Board||2.83yrs||zł45.00k||no data|
|Member of the Supervisory Board||2.83yrs||zł45.00k||no data|
|Member of the Supervisory Board||1.83yrs||zł3.00k||no data|
|Member of the Supervisory Board||no data||zł16.00k||no data|
Experienced Board: EMC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 67%.
EMC Instytut Medyczny SA's company bio, employee growth, exchange listings and data sources
- Name: EMC Instytut Medyczny SA
- Ticker: EMC
- Exchange: WSE
- Founded: 2001
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: zł288.452m
- Shares outstanding: 22.19m
- Website: https://www.emc-sa.pl
- EMC Instytut Medyczny SA
- ul. Pilczycka 144-148
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|EMC||WSE (Warsaw Stock Exchange)||Yes||Common Bearer Shares||PL||PLN||Jul 2005|
|0LTC||LSE (London Stock Exchange)||Yes||Common Bearer Shares||GB||PLN||Jul 2005|
EMC Instytut Medyczny SA owns hospitals and outpatient clinics in the private medical services market in Poland. The company was founded in 2001 and is based in Wroclaw, Poland.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/12/01 18:03|
|End of Day Share Price||2020/12/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.